PSMA-Based Radiopharmaceuticals in Prostate Cancer Theranostics: Imaging, Clinical Advances, and Future Directions.

Cancers (Basel) · 2026 · PMC12838653 · PMID 41595153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the overall survival (OS) in the interim OS analysis favored [ 177 Lu]Lu-PSMA-617, the results did not reach statistical significance, partly due to crossover bias (HR 0.91).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.